Overview

Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects

Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The objective is to evaluate the safety and tolerability of a single-ascending oral dose of UV-4B in healthy subjects and to determine pharmacokinetic parameters describing absorption and elimination following a single dose of UV-4B in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Unither Virology
Collaborators:
Emergent BioSolutions
Quintiles, Inc.
Treatments:
Pharmaceutical Solutions